Publication | Closed Access

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

Pegylated-interferon Plus RibavirinPre-treatment PredictionAutoimmune DiseaseHepatitis CHepatologyViral HepatitisImmunologyGenetic EpidemiologyHepatitisAntiviral TherapyLiver DiseaseChronic Viral InfectionMedicineImmune-related Gene PolymorphismChronic Hepatitis C